The firm is the first and only U.S. affiliate dedicated to the biotech investment of Mirae Asset, a prominent global financial group overseeing nearly $600bn AUM across a diversified platform, who has ...

On Second Thought Wednesday's headline on Ignites (a paywalled trade-industry site, no link) read, "Target-Date Funds Can't Beat 60/40 Funds: Study." I assumed the study compared the total returns of ...

Asset allocation is a major determinant of investment returns, according to financial economists. This popular investment strategy balances returns with risk by dividing a portfolio among various ...

Clinical trial tech company Science 37 announced Thursday it has acquired a life science platform from Vault Health, which offers COVID-19 testing and health-screening services for employers. Science ...

Dublin, March 12, 2026 (GLOBE NEWSWIRE)-- The "Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2026" report has been added to ResearchAndMarkets.com's offering. The Asset Purchase Deals ...

On Apr 7, we issued an updated research report on Ventas, Inc. VTR. The company’s capital allocation to office segment assets, including life science, medical office buildings (MOBs) and research & ...

Asset lifecycle management refers to the strategies used to extend the time that an asset functions. A longer asset lifespan means a more efficient business, so lifecycle management ultimately boosts ...

Onchain Custodian, a digital assets custody platform, has partnered with blockchain transaction monitoring intelligence company Merkle Science to combat the criminal use of crypto assets. The ...

The office’s request for information is the latest piece in the massive research agenda in President Biden’s executive order on digital asset development. The administration of United States President ...

HELA is the mascot of Decentralized Science (DeSci) movement, striving to make science popular and fun (again). Inspired by the discovery of HeLa cells, one of the most valuable and timeless ...

Our Weekly View is typically a timely look at recent market-moving news, what RiverFront thinks about it, and how it may or may not affect our portfolio positioning. Today is a bit different. We are ...